|
Re: Checklist for Management
|
3
|
Resverlogix Corp.
|
Jul 11, 2016 04:17PM
|
|
Re: Anacetrapib Officially Bites the Dust
|
3
|
Resverlogix Corp.
|
Oct 26, 2017 12:41PM
|
|
Re: 4-8b guess - Is someone asking too much?
|
3
|
Resverlogix Corp.
|
Dec 09, 2019 11:13AM
|
|
Re: Zenith Corporate Update
|
3
|
Zenith Epigenetics
|
Dec 02, 2016 02:50PM
|
|
Re: Blog post up on Seeking Alpha....lots of changes.
|
3
|
Resverlogix Corp.
|
Mar 27, 2019 11:07AM
|
|
Re: 3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
3
|
Resverlogix Corp.
|
Nov 06, 2018 11:09AM
|
|
Any day now.......
|
3
|
Zenith Epigenetics
|
May 05, 2016 11:25AM
|
|
Re: American Association for Cancer Research 2019
|
3
|
Zenith Epigenetics
|
Mar 29, 2019 09:13PM
|
|
Re: BTI just filed a Other securityholders documents - English
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 16, 2018 01:22PM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 04:00PM
|
|
Remaining Q2 2016 Events (RVX and Zenith)
|
3
|
Resverlogix Corp.
|
May 05, 2016 11:32AM
|
|
Re: Next private placement/licensing agreement
|
3
|
Resverlogix Corp.
|
Feb 07, 2019 11:24AM
|
|
Re: I'm not watching super close....
|
3
|
Resverlogix Corp.
|
Jul 01, 2019 05:36PM
|
|
FDA approves Migalastat (Galafold) from Amicus for Fabry disease
|
3
|
Resverlogix Corp.
|
Aug 11, 2018 01:25PM
|
|
Re: webcast
|
3
|
Resverlogix Corp.
|
Feb 26, 2016 02:35PM
|
|
Re: Why such little intrest, so close to the finis
|
3
|
Resverlogix Corp.
|
Nov 16, 2018 09:18PM
|
|
Not all top-line news releases look the same
|
3
|
Resverlogix Corp.
|
Jun 18, 2019 02:58PM
|
|
Re: Why Resverlogix is important to Zenith, and vice versa?
|
3
|
Resverlogix Corp.
|
Dec 03, 2015 04:59PM
|
|
Re: Notice of Meeting and Information Circular on SEDAR
|
3
|
Resverlogix Corp.
|
Aug 11, 2018 01:29PM
|
|
Re: A taxable versus a non taxable sale
|
3
|
Zenith Epigenetics
|
Sep 13, 2018 09:13AM
|
